Publications
Discovery of BBO-8520, a first-in-class direct and covalent dual inhibitor of GTP-bound (ON) and GDP-bound (OFF) KRASG12C. Cancer Discov. 10.1158/2159-8290.CD-24-0840
(2024) (2021) NECAT
9700 S. Cass Ave.
Bldg. 436E
Argonne, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2025, NECAT
Design by FreeBiezz